IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells | Diabetologia https://t.co/Vwz4fnQbcT
RT @Brunorm84: IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells #ERstress #diabetes @Diab…
RT @Brunorm84: IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells #ERstress #diabetes @Diab…
IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells #ERstress #diabetes @DiabetologiaJnl https://t.co/6kfBpT3zAG
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @profsmarshall: Free to read in March @DiabetologiaJnl : IFN-α induces a preferential long-lasting expression of MHC class I in human pa…
RT @profsmarshall: Free to read in March @DiabetologiaJnl : IFN-α induces a preferential long-lasting expression of MHC class I in human pa…
RT @profsmarshall: Free to read in March @DiabetologiaJnl : IFN-α induces a preferential long-lasting expression of MHC class I in human pa…
RT @profsmarshall: Free to read in March @DiabetologiaJnl : IFN-α induces a preferential long-lasting expression of MHC class I in human pa…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
Free to read in March @DiabetologiaJnl : IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells by Coomans de Brachène et al https://t.co/RjUjEkO0rS #EditorsChoice https://t.co/Qag6eqOS1m
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
RT @DiabetologiaJnl: JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they m…
JAK inhibitors, already used in the treatment of #autoimmune diseases, may protect #betacells in #T1D. However, they must be introduced early—probably ahead of clinical onset https://t.co/CGpTXXmfRX https://t.co/wvvgsbViWh
JAK inhibitors prevent IFN-alpha-induced #MHC class I overexpression in #pancreatic #betacells, but only when added prospectively. #T1D https://t.co/CGpTXXmfRX https://t.co/RN7O8GwDFY
RT @DiabetologiaJnl: IFN-α induces a preferential long-lasting expression of #MHC class I in human #pancreatic #betacells. #T1D https://t.c…
RT @DiabetologiaJnl: IFN-α induces a preferential long-lasting expression of #MHC class I in human #pancreatic #betacells. #T1D https://t.c…
IFN-α induces a preferential long-lasting expression of #MHC class I in human #pancreatic #betacells. #T1D https://t.co/CGpTXXmfRX https://t.co/ra4fsFwOkk
RT @PancreaticCell: IFN-α Induces a Preferential Long-Lasting Expression of MHC Class I in Human Pancreatic Beta Cells @iumedschool @ULBrux…
RT @HIRN_CC: New HIRN Publication. Thanks for sharing @PancreaticCell #HIRN #BetaMarker @MirmiraLab @IUSweetTweets @ULBruxelles https://…
New HIRN Publication. Thanks for sharing @PancreaticCell #HIRN #BetaMarker @MirmiraLab @IUSweetTweets @ULBruxelles https://t.co/qSqzE9KDMy
RT @PancreaticCell: IFN-α Induces a Preferential Long-Lasting Expression of MHC Class I in Human Pancreatic Beta Cells @iumedschool @ULBrux…
RT @PancreaticCell: IFN-α Induces a Preferential Long-Lasting Expression of MHC Class I in Human Pancreatic Beta Cells @iumedschool @ULBrux…
RT @PancreaticCell: IFN-α Induces a Preferential Long-Lasting Expression of MHC Class I in Human Pancreatic Beta Cells @iumedschool @ULBrux…
IFN-α Induces a Preferential Long-Lasting Expression of MHC Class I in Human Pancreatic Beta Cells @iumedschool @ULBruxelles @Unipisa https://t.co/ZxGypjAIe9
ULB collega's hun laatste werk https://t.co/qZFdNoUiDT
RT @rsdossantos13: Our most recent paper is now online! @lmarroqui @DiabetologiaJnl https://t.co/TBDmjlbWHD
RT @rsdossantos13: Our most recent paper is now online! @lmarroqui @DiabetologiaJnl https://t.co/TBDmjlbWHD
Our most recent paper is now online! @lmarroqui @DiabetologiaJnl https://t.co/TBDmjlbWHD